US Patent 10550159 None
Patent 10550159 was granted and assigned to Pfizer Limited on February, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 11 Dec, 2023
Golden AI
Edits made to:
Article (+458 characters)
Article
Patent abstract
In one aspect, the invention relates to a non-lipidated and non-pyruvylated Neisseria meningitidis serogroup B polypeptide and methods of use thereof. In another aspect, the invention relates to an immunogenic composition including an isolated non-lipidated, non-pyruvylated ORF2086 polypeptide from Neisseria meningitidis serogroup B, and at least one conjugated capsular saccharide from a meningococcal serogroup, and methods of use thereof.
Edits on 21 Jun, 2023
Golden AI
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
105501590
Date of Patent
February 4, 2020
0Patent Application Number
162083470
Date Filed
December 3, 2018
0Patent Citations Received
Patent Primary Examiner
Edits on 30 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 28 Oct, 2022
Golden AI
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
105501590
Date of Patent
February 4, 2020
0Patent Application Number
162083470
Date Filed
December 3, 2018
0Patent Citations Received
Patent Primary Examiner
Edits on 9 Feb, 2022
Golden AI
Golden AI
Edits on 7 Feb, 2022
Golden AI
Golden AI
Edits on 1 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10550159 None
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10550159
Date of patent
February 4, 2020
Patent application number
16208347
Date Filed
December 3, 2018
Patent primary examiner
Find more entities like US Patent 10550159 None
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
